Boyce Sarah

CIK 00016293834 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001629383

Recent Transactions

50 trades

Gift
Avidity Biosciences, Inc.$RNA
Common Stock
2025-12-18−29,159→ 291,970 total
Award
Avidity Biosciences, Inc.$RNA
Common Stock
2025-12-17+31,000→ 336,871 total
Tax Payment
Avidity Biosciences, Inc.$RNA
Common Stock
2025-12-17$71.87/sh−15,742→ 321,129 total
Sale
Avidity Biosciences, Inc.$RNA
Common Stock
2024-12-18$32.66/sh−31,855→ 265,308 total
Sale
Avidity Biosciences, Inc.$RNA
Common Stock
2024-09-23$44.00/sh−32,880→ 234,663 total
Award
Avidity Biosciences, Inc.$RNA
Common Stock
2024-09-19+62,500→ 297,163 total
Award
Avidity Biosciences, Inc.$RNA
Common Stock
2024-09-19+62,500→ 267,543 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Stock Option (Right to Buy)
2024-08-06−28,000→ 461,015 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Common Stock
2024-08-06$1.24/sh+28,000→ 233,043 total
Sale
Avidity Biosciences, Inc.$RNA
Common Stock
2024-08-06$43.35/sh−28,000→ 205,043 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Stock Option (Right to Buy)
2024-07-09−28,000→ 489,015 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Common Stock
2024-07-09$1.24/sh+28,000→ 233,043 total
Sale
Avidity Biosciences, Inc.$RNA
Common Stock
2024-07-09$39.93/sh−28,000→ 205,043 total
Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2024-06-24+29,500→ 29,500 total
Exercise/Conversion
OmniAb, Inc.$OABI
Restricted Stock Units
2024-06-18−20,000→ 0 total
Award
OmniAb, Inc.$OABI
Stock Option (right to buy)
2024-06-18+40,000→ 40,000 total
Sale
Avidity Biosciences, Inc.$RNA
Common Stock
2024-06-18$39.13/sh−32,074→ 142,543 total
Exercise/Conversion
OmniAb, Inc.$OABI
Common Stock
2024-06-18+20,000→ 68,381 total
Award
OmniAb, Inc.$OABI
Restricted Stock Units
2024-06-18+20,000→ 20,000 total
Award
Avidity Biosciences, Inc.$RNA
Common Stock
2024-06-17+62,500→ 174,617 total
Award
Avidity Biosciences, Inc.$RNA
Common Stock
2024-06-17+62,500→ 205,043 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Stock Option (Right to Buy)
2024-06-14−35,767→ 517,015 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Common Stock
2024-06-14$1.24/sh+35,767→ 147,884 total
Sale
Avidity Biosciences, Inc.$RNA
Common Stock
2024-06-14$40.08/sh−35,767→ 112,117 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Common Stock
2024-06-13$1.24/sh+164,233→ 276,350 total
Sale
Avidity Biosciences, Inc.$RNA
Common Stock
2024-06-13$40.08/sh−164,233→ 112,117 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Stock Option (Right to Buy)
2024-06-13−164,233→ 552,782 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Stock Option (Right to Buy)
2024-06-12−100,000→ 717,015 total
Sale
Avidity Biosciences, Inc.$RNA
Common Stock
2024-06-12$35.73/sh−100,000→ 112,117 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Common Stock
2024-06-12$1.24/sh+100,000→ 212,117 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Common Stock
2024-06-04$1.24/sh+28,000→ 140,117 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Stock Option (Right to Buy)
2024-06-04−28,000→ 817,015 total
Sale
Avidity Biosciences, Inc.$RNA
Common Stock
2024-06-04$27.42/sh−28,000→ 112,117 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Common Stock
2024-05-07$1.24/sh+28,000→ 140,117 total
Sale
Avidity Biosciences, Inc.$RNA
Common Stock
2024-05-07$25.54/sh−28,000→ 112,117 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Stock Option (Right to Buy)
2024-05-07−28,000→ 845,015 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Stock Option (Right to Buy)
2024-04-02−28,000→ 873,015 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Common Stock
2024-04-02$1.24/sh+28,000→ 140,117 total
Sale
Avidity Biosciences, Inc.$RNA
Common Stock
2024-04-02$26.25/sh−28,000→ 112,117 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Stock Option (Right to Buy)
2024-03-12−28,000→ 901,015 total
Sale
Avidity Biosciences, Inc.$RNA
Common Stock
2024-03-12$22.63/sh−28,000→ 112,117 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Common Stock
2024-03-12$1.24/sh+28,000→ 140,117 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Common Stock
2024-03-08$1.24/sh+84,000→ 196,117 total
Sale
Avidity Biosciences, Inc.$RNA
Common Stock
2024-03-08$21.39/sh−84,000→ 112,117 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Stock Option (Right to Buy)
2024-03-08−84,000→ 929,015 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Common Stock
2024-03-01$1.24/sh+84,000→ 196,117 total
Sale
Avidity Biosciences, Inc.$RNA
Common Stock
2024-03-01$20.13/sh−84,000→ 112,117 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNA
Stock Option (Right to Buy)
2024-03-01−84,000→ 1,013,015 total
Sale
Avidity Biosciences, Inc.$RNA
Common Stock
2024-01-22$10.13/sh−5,092→ 44,008 total
Award
Avidity Biosciences, Inc.$RNA
Stock Option (Right to Buy)
2024-01-20+300,000→ 300,000 total

Companies

Recent Filings

Address

C/O AVIDITY BIOSCIENCES, INC. 3020 CALLAN RD.

SAN DIEGO, CA, 92121

View on SEC.gov